Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8 |
Intermediate Similarity |
NPD5728 |
Clinical (unspecified phase) |
0.7931 |
Intermediate Similarity |
NPD2509 |
Approved |
0.7931 |
Intermediate Similarity |
NPD2510 |
Approved |
0.7865 |
Intermediate Similarity |
NPD2091 |
Phase 2 |
0.7865 |
Intermediate Similarity |
NPD2096 |
Phase 2 |
0.7843 |
Intermediate Similarity |
NPD7947 |
Clinical (unspecified phase) |
0.7826 |
Intermediate Similarity |
NPD8094 |
Discontinued |
0.7812 |
Intermediate Similarity |
NPD2094 |
Phase 2 |
0.7812 |
Intermediate Similarity |
NPD2092 |
Phase 2 |
0.7812 |
Intermediate Similarity |
NPD2095 |
Phase 2 |
0.7789 |
Intermediate Similarity |
NPD2144 |
Approved |
0.7778 |
Intermediate Similarity |
NPD8093 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD482 |
Approved |
0.7772 |
Intermediate Similarity |
NPD3607 |
Clinical (unspecified phase) |
0.7761 |
Intermediate Similarity |
NPD8248 |
Clinical (unspecified phase) |
0.776 |
Intermediate Similarity |
NPD3038 |
Discontinued |
0.7749 |
Intermediate Similarity |
NPD4076 |
Approved |
0.7749 |
Intermediate Similarity |
NPD4079 |
Approved |
0.7737 |
Intermediate Similarity |
NPD749 |
Clinical (unspecified phase) |
0.7696 |
Intermediate Similarity |
NPD3505 |
Approved |
0.7696 |
Intermediate Similarity |
NPD5426 |
Phase 3 |
0.7696 |
Intermediate Similarity |
NPD5901 |
Discontinued |
0.7696 |
Intermediate Similarity |
NPD3506 |
Approved |
0.7684 |
Intermediate Similarity |
NPD5065 |
Approved |
0.7667 |
Intermediate Similarity |
NPD3389 |
Approved |
0.7667 |
Intermediate Similarity |
NPD3394 |
Approved |
0.7667 |
Intermediate Similarity |
NPD3393 |
Approved |
0.766 |
Intermediate Similarity |
NPD5069 |
Clinical (unspecified phase) |
0.7659 |
Intermediate Similarity |
NPD7001 |
Phase 3 |
0.7659 |
Intermediate Similarity |
NPD6732 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD2121 |
Clinical (unspecified phase) |
0.7644 |
Intermediate Similarity |
NPD7470 |
Discontinued |
0.7626 |
Intermediate Similarity |
NPD6630 |
Clinical (unspecified phase) |
0.7624 |
Intermediate Similarity |
NPD7000 |
Clinical (unspecified phase) |
0.7624 |
Intermediate Similarity |
NPD6999 |
Discontinued |
0.7621 |
Intermediate Similarity |
NPD6838 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD4184 |
Clinical (unspecified phase) |
0.7617 |
Intermediate Similarity |
NPD6595 |
Phase 3 |
0.7596 |
Intermediate Similarity |
NPD7809 |
Clinical (unspecified phase) |
0.7596 |
Intermediate Similarity |
NPD7998 |
Clinical (unspecified phase) |
0.7573 |
Intermediate Similarity |
NPD4862 |
Clinical (unspecified phase) |
0.7573 |
Intermediate Similarity |
NPD7957 |
Phase 1 |
0.7573 |
Intermediate Similarity |
NPD7958 |
Clinical (unspecified phase) |
0.7563 |
Intermediate Similarity |
NPD8431 |
Approved |
0.7539 |
Intermediate Similarity |
NPD750 |
Phase 2 |
0.7536 |
Intermediate Similarity |
NPD8112 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD484 |
Approved |
0.75 |
Intermediate Similarity |
NPD4601 |
Approved |
0.75 |
Intermediate Similarity |
NPD4600 |
Approved |
0.7474 |
Intermediate Similarity |
NPD2844 |
Phase 3 |
0.7451 |
Intermediate Similarity |
NPD7621 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD6664 |
Approved |
0.743 |
Intermediate Similarity |
NPD8405 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD7825 |
Clinical (unspecified phase) |
0.7427 |
Intermediate Similarity |
NPD5721 |
Clinical (unspecified phase) |
0.7426 |
Intermediate Similarity |
NPD7618 |
Phase 3 |
0.7426 |
Intermediate Similarity |
NPD7619 |
Phase 3 |
0.7426 |
Intermediate Similarity |
NPD7944 |
Discontinued |
0.7416 |
Intermediate Similarity |
NPD7666 |
Phase 3 |
0.7416 |
Intermediate Similarity |
NPD7665 |
Phase 2 |
0.7393 |
Intermediate Similarity |
NPD8013 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD8072 |
Approved |
0.7387 |
Intermediate Similarity |
NPD3486 |
Clinical (unspecified phase) |
0.7363 |
Intermediate Similarity |
NPD6180 |
Clinical (unspecified phase) |
0.7356 |
Intermediate Similarity |
NPD6987 |
Phase 1 |
0.7356 |
Intermediate Similarity |
NPD8272 |
Phase 2 |
0.7353 |
Intermediate Similarity |
NPD7948 |
Phase 1 |
0.735 |
Intermediate Similarity |
NPD8110 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD5899 |
Approved |
0.7347 |
Intermediate Similarity |
NPD5897 |
Approved |
0.7347 |
Intermediate Similarity |
NPD5898 |
Approved |
0.7337 |
Intermediate Similarity |
NPD4426 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD6203 |
Clinical (unspecified phase) |
0.7313 |
Intermediate Similarity |
NPD3871 |
Clinical (unspecified phase) |
0.7313 |
Intermediate Similarity |
NPD3870 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD3178 |
Discontinued |
0.7297 |
Intermediate Similarity |
NPD4462 |
Approved |
0.7297 |
Intermediate Similarity |
NPD2172 |
Phase 1 |
0.7297 |
Intermediate Similarity |
NPD4463 |
Approved |
0.7295 |
Intermediate Similarity |
NPD7903 |
Clinical (unspecified phase) |
0.7293 |
Intermediate Similarity |
NPD1592 |
Phase 3 |
0.7292 |
Intermediate Similarity |
NPD4638 |
Approved |
0.7292 |
Intermediate Similarity |
NPD4639 |
Approved |
0.7292 |
Intermediate Similarity |
NPD4640 |
Approved |
0.7286 |
Intermediate Similarity |
NPD8493 |
Clinical (unspecified phase) |
0.7286 |
Intermediate Similarity |
NPD6610 |
Clinical (unspecified phase) |
0.7282 |
Intermediate Similarity |
NPD4075 |
Phase 2 |
0.7281 |
Intermediate Similarity |
NPD6242 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD786 |
Approved |
0.7277 |
Intermediate Similarity |
NPD5744 |
Clinical (unspecified phase) |
0.7277 |
Intermediate Similarity |
NPD5592 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD5596 |
Phase 2 |
0.7268 |
Intermediate Similarity |
NPD5003 |
Discontinued |
0.7264 |
Intermediate Similarity |
NPD7234 |
Approved |
0.7264 |
Intermediate Similarity |
NPD7233 |
Approved |
0.726 |
Intermediate Similarity |
NPD8073 |
Approved |
0.7254 |
Intermediate Similarity |
NPD1326 |
Approved |
0.7254 |
Intermediate Similarity |
NPD1325 |
Approved |
0.724 |
Intermediate Similarity |
NPD6165 |
Phase 2 |
0.724 |
Intermediate Similarity |
NPD6164 |
Phase 2 |
0.7233 |
Intermediate Similarity |
NPD7778 |
Approved |
0.7233 |
Intermediate Similarity |
NPD7777 |
Approved |
0.7233 |
Intermediate Similarity |
NPD53 |
Approved |
0.7228 |
Intermediate Similarity |
NPD4499 |
Approved |
0.7225 |
Intermediate Similarity |
NPD6176 |
Phase 1 |
0.7225 |
Intermediate Similarity |
NPD5138 |
Approved |
0.7225 |
Intermediate Similarity |
NPD5140 |
Approved |
0.7222 |
Intermediate Similarity |
NPD8000 |
Clinical (unspecified phase) |
0.722 |
Intermediate Similarity |
NPD7818 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD2511 |
Approved |
0.7206 |
Intermediate Similarity |
NPD5575 |
Clinical (unspecified phase) |
0.7198 |
Intermediate Similarity |
NPD6661 |
Clinical (unspecified phase) |
0.7198 |
Intermediate Similarity |
NPD1722 |
Approved |
0.7196 |
Intermediate Similarity |
NPD7594 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD56 |
Approved |
0.719 |
Intermediate Similarity |
NPD8283 |
Approved |
0.719 |
Intermediate Similarity |
NPD8282 |
Approved |
0.7189 |
Intermediate Similarity |
NPD4703 |
Approved |
0.7189 |
Intermediate Similarity |
NPD4702 |
Approved |
0.7183 |
Intermediate Similarity |
NPD4051 |
Discontinued |
0.7172 |
Intermediate Similarity |
NPD5473 |
Discontinued |
0.717 |
Intermediate Similarity |
NPD8423 |
Phase 2 |
0.717 |
Intermediate Similarity |
NPD8399 |
Phase 1 |
0.7157 |
Intermediate Similarity |
NPD4181 |
Approved |
0.7151 |
Intermediate Similarity |
NPD3100 |
Discontinued |
0.715 |
Intermediate Similarity |
NPD4614 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD8326 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD2564 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4736 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD2565 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD8327 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD8325 |
Phase 3 |
0.7135 |
Intermediate Similarity |
NPD5088 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD3323 |
Discontinued |
0.7129 |
Intermediate Similarity |
NPD3961 |
Discontinued |
0.7122 |
Intermediate Similarity |
NPD1038 |
Approved |
0.7117 |
Intermediate Similarity |
NPD8289 |
Discontinued |
0.7116 |
Intermediate Similarity |
NPD4852 |
Phase 2 |
0.7111 |
Intermediate Similarity |
NPD198 |
Clinical (unspecified phase) |
0.711 |
Intermediate Similarity |
NPD7878 |
Phase 2 |
0.7108 |
Intermediate Similarity |
NPD2336 |
Approved |
0.7107 |
Intermediate Similarity |
NPD2381 |
Approved |
0.7107 |
Intermediate Similarity |
NPD6375 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD2380 |
Approved |
0.7107 |
Intermediate Similarity |
NPD2382 |
Approved |
0.7098 |
Intermediate Similarity |
NPD7824 |
Approved |
0.7098 |
Intermediate Similarity |
NPD1568 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD7187 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD3794 |
Approved |
0.7083 |
Intermediate Similarity |
NPD3795 |
Approved |
0.7081 |
Intermediate Similarity |
NPD4501 |
Approved |
0.7081 |
Intermediate Similarity |
NPD4500 |
Approved |
0.7081 |
Intermediate Similarity |
NPD6479 |
Discontinued |
0.7072 |
Intermediate Similarity |
NPD7269 |
Clinical (unspecified phase) |
0.7071 |
Intermediate Similarity |
NPD8123 |
Approved |
0.7071 |
Intermediate Similarity |
NPD8122 |
Approved |
0.707 |
Intermediate Similarity |
NPD7927 |
Clinical (unspecified phase) |
0.7065 |
Intermediate Similarity |
NPD7564 |
Discontinued |
0.7065 |
Intermediate Similarity |
NPD6178 |
Phase 3 |
0.7059 |
Intermediate Similarity |
NPD6281 |
Approved |
0.7056 |
Intermediate Similarity |
NPD4128 |
Approved |
0.7053 |
Intermediate Similarity |
NPD6026 |
Approved |
0.7044 |
Intermediate Similarity |
NPD4948 |
Discontinued |
0.704 |
Intermediate Similarity |
NPD7603 |
Discontinued |
0.7035 |
Intermediate Similarity |
NPD8386 |
Phase 2 |
0.7028 |
Intermediate Similarity |
NPD8114 |
Approved |
0.7028 |
Intermediate Similarity |
NPD3947 |
Discontinued |
0.7028 |
Intermediate Similarity |
NPD8115 |
Approved |
0.7028 |
Intermediate Similarity |
NPD7712 |
Clinical (unspecified phase) |
0.702 |
Intermediate Similarity |
NPD5100 |
Phase 3 |
0.7015 |
Intermediate Similarity |
NPD3320 |
Approved |
0.7015 |
Intermediate Similarity |
NPD3319 |
Phase 1 |
0.7015 |
Intermediate Similarity |
NPD3318 |
Approved |
0.7009 |
Intermediate Similarity |
NPD7731 |
Approved |
0.7009 |
Intermediate Similarity |
NPD7730 |
Approved |
0.7005 |
Intermediate Similarity |
NPD5975 |
Clinical (unspecified phase) |
0.7004 |
Intermediate Similarity |
NPD7953 |
Approved |
0.7004 |
Intermediate Similarity |
NPD7951 |
Approved |
0.7004 |
Intermediate Similarity |
NPD7790 |
Approved |
0.7004 |
Intermediate Similarity |
NPD7791 |
Approved |
0.7004 |
Intermediate Similarity |
NPD7952 |
Approved |
0.7004 |
Intermediate Similarity |
NPD7950 |
Approved |
0.7004 |
Intermediate Similarity |
NPD7789 |
Approved |
0.7 |
Intermediate Similarity |
NPD5257 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD2481 |
Approved |
0.7 |
Intermediate Similarity |
NPD8464 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD2479 |
Phase 3 |
0.6995 |
Remote Similarity |
NPD7010 |
Phase 3 |
0.6991 |
Remote Similarity |
NPD8372 |
Clinical (unspecified phase) |
0.699 |
Remote Similarity |
NPD3404 |
Approved |
0.6986 |
Remote Similarity |
NPD8406 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD6995 |
Phase 1 |
0.6981 |
Remote Similarity |
NPD2920 |
Discontinued |
0.6978 |
Remote Similarity |
NPD7780 |
Approved |
0.6978 |
Remote Similarity |
NPD7781 |
Approved |
0.6977 |
Remote Similarity |
NPD2125 |
Clinical (unspecified phase) |
0.6973 |
Remote Similarity |
NPD3717 |
Discontinued |
0.6972 |
Remote Similarity |
NPD7707 |
Approved |
0.6971 |
Remote Similarity |
NPD2307 |
Discontinued |
0.6968
|
Remote Similarity |
NPD4374 |
Clinical (unspecified phase) |